✦ LIBER ✦

Diabetic nephropathy: Renoprotective effects of angiotensin 1–7

✍ Scribed by Carney, Ellen F.

Book ID: 121659510
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 634 KB
Volume: 10
Category: Article
ISSN: 1759-5061
DOI: 10.1038/nrneph.2014.39

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Candesartan renoprotective in diabetic n

Candesartan renoprotective in diabetic nephropathy

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Diabetic nephropathy: Renoprotective eff

Diabetic nephropathy: Renoprotective effects of pentoxifylline in the PREDIAN trial

✍ He, Tony; Cooper, Mark E. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Renoprotective effects of low-dose valsa

Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy

✍ Katsunori Suzuki; Satoshi Souda; Tomoo Ikarashi; Susumu Kaneko; Osamu Nakagawa; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Renoprotective effects of vasopeptidase

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy

✍ B. J. Davis; C. I. Johnston; L. M. Burrell; W. C. Burns; E. Kubota; Z. Cao; M. E 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 646 KB

Renoprotective Effect of the Angiotensin

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

✍ Lewis, Edmund J.; Hunsicker, Lawrence G.; Clarke, William R.; Berl, Tomas; Pohl, 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 193 KB

Renoprotective effects of the angiotensi

Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

✍ E.J Lewis; L.G Hunsicker; W.R Clarkeet al 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 38 KB